BidaskClub Lowers iKang Healthcare Group (KANG) to Hold

BidaskClub downgraded shares of iKang Healthcare Group (NASDAQ:KANG) from a buy rating to a hold rating in a research note released on Wednesday morning.

Separately, ValuEngine upgraded shares of iKang Healthcare Group from a sell rating to a hold rating in a report on Monday, April 2nd.

iKang Healthcare Group opened at $20.00 on Wednesday, according to Marketbeat. The company has a quick ratio of 0.74, a current ratio of 0.76 and a debt-to-equity ratio of 0.03. iKang Healthcare Group has a 12-month low of $11.70 and a 12-month high of $20.14. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 76.89 and a beta of 0.07.

iKang Healthcare Group (NASDAQ:KANG) last posted its quarterly earnings results on Thursday, March 22nd. The medical research company reported $0.40 earnings per share (EPS) for the quarter. iKang Healthcare Group had a net margin of 3.16% and a return on equity of 4.97%. The business had revenue of $206.39 million during the quarter.

Several institutional investors have recently bought and sold shares of KANG. California Public Employees Retirement System purchased a new stake in shares of iKang Healthcare Group during the third quarter worth about $888,000. SG Americas Securities LLC boosted its holdings in shares of iKang Healthcare Group by 48.7% during the fourth quarter. SG Americas Securities LLC now owns 67,573 shares of the medical research company’s stock worth $1,068,000 after purchasing an additional 22,139 shares during the period. Kontiki Capital Management HK Ltd. purchased a new stake in shares of iKang Healthcare Group during the fourth quarter worth about $5,276,000. State of Wisconsin Investment Board boosted its holdings in shares of iKang Healthcare Group by 643.5% during the fourth quarter. State of Wisconsin Investment Board now owns 148,700 shares of the medical research company’s stock worth $2,349,000 after purchasing an additional 128,700 shares during the period. Finally, BlackRock Inc. boosted its holdings in shares of iKang Healthcare Group by 5.8% during the fourth quarter. BlackRock Inc. now owns 801,734 shares of the medical research company’s stock worth $12,669,000 after purchasing an additional 43,981 shares during the period. Institutional investors own 35.53% of the company’s stock.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply